• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Dolby Laboratories Reports First Quarter 2025 Financial Results

    1/29/25 4:15:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous
    Get the next $DLB alert in real time by email

    SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025.

    Dolby logo (PRNewsfoto/Dolby Laboratories, Inc.)

    "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories. "In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto."

    First Quarter Fiscal 2025 Financial Highlights

    • Total revenue was $357 million, compared to $316 million for the first quarter of fiscal 2024.
    • GAAP net income was $68 million or $0.70 per diluted share, compared to GAAP net income of $67 million or $0.69 per diluted share for the first quarter of fiscal 2024. On a non-GAAP basis, first quarter net income was $111 million or $1.14 per diluted share, compared to $99 million or $1.01 per diluted share for the first quarter of fiscal 2024.
    • Dolby repurchased approximately 186,000 shares of its common stock for approximately $15 million, and ended the quarter with approximately $387 million of stock repurchase authorization available going forward.

    A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

    Recent Business Highlights

    • At CES, our partners announced a wide range of new products incorporating Dolby technologies, including:
      • Soundbar announcements from Harmon Kardon, Samsung, and Amazon all support Dolby technology.
      • TV launches from partners including Hisense, TCL, Panasonic, Sharp, and RCA support Dolby Atmos and Dolby Vision.
      • In Auto, Samsung Display is working with Dolby to pre tune its cutting edge OLED displays for autos to deliver Dolby Vision to more cars, Texas Instruments announced that it would support Dolby Atmos in its new family of chips for automakers, and Pioneer showcased how Dolby Atmos could be used in an aftermarket solution using a 4-channel speaker system.
      • In PCs, ASUS, Dell, Lenovo, and Samsung announced a variety of new PCs, laptops, and monitors that support Dolby Vision and/or Dolby Atmos.
    • Social Media app Xiaohongshu, which goes by the name RedNote in the U.S., now supports Dolby Vision.
    • Amazon announced that the Fire TV Omni Mini-LED will support Dolby Atmos and Dolby Vision.
    • All eight of the 2025 Grammy nominees for best new artist are available in Dolby Atmos, and seven out of eight Grammy nominees for Record of the Year and Album of the Year are available in Dolby Atmos.
    • In 2024, over 80% of domestic box office and almost 70% of global box office came from Hollywood and local titles released in Dolby Atmos and Dolby Vision.

    Dividend

    Today, Dolby announced a cash dividend of $0.33 per share of Class A and Class B common stock, payable on February 19, 2025, to stockholders of record as of the close of business on February 11, 2025.

    Financial Outlook

    Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the first quarter of fiscal 2025, to be filed on or around the date hereof.

    Dolby is providing the following estimates for its second quarter of fiscal 2025:

    • Total revenue is estimated to range from $355 million to $385 million.
    • Licensing revenue is estimated to range from $330 million to $360 million. 
    • Gross margins are anticipated to be approximately 89% on a GAAP basis and approximately 91% on a non-GAAP basis.
    • Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $190 million to $200 million on a non-GAAP basis.
    • Effective tax rate is anticipated to be around 20.5% on a GAAP basis and around 18.5% on a non-GAAP basis.
    • Diluted earnings per share is anticipated to range from $0.77 to $0.92 on a GAAP basis and from $1.19 to $1.34 on a non-GAAP basis.

    Dolby is providing the following estimates for the full year of fiscal 2025:

    • Total revenue is expected to range from $1.33 billion to $1.39 billion.
    • Licensing revenue is estimated to range from $1.22 billion to $1.28 billion. 
    • Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.
    • Operating expenses are anticipated to range from $915 million to $925 million on a GAAP basis and from $765 million to $775 million on a non-GAAP basis.
    • Dolby expects operating margins to be roughly 20% on a GAAP basis and to be roughly 33% on a non-GAAP basis.
    • Diluted earnings per share is anticipated to range from $2.39 to $2.54 on a GAAP basis and from $3.99 to $4.14 on a non-GAAP basis.

    Conference Call Information

    Members of Dolby management will lead a conference call open to all interested parties to discuss first quarter fiscal 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Wednesday, January 29, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-800-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

    A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Wednesday, January 29, 2025, until 8:59 p.m. PT (11:59 p.m. ET) on Wednesday, February 5, 2025 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

    Non-GAAP Financial Information

    To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

    Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

    Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

    Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

    Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

    Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

    Forward-Looking Statements

    Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the second quarter of fiscal 2025 and full year fiscal 2025, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

    About Dolby Laboratories

    Dolby Laboratories (NYSE:DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. Dolby partners with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

    Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.

    DOLBY LABORATORIES, INC.

    INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (in thousands, except per share amounts; unaudited)





    Fiscal Quarter Ended



    December 27,

    2024

    December 29,

    2023

    Revenue:





       Licensing

    $                330,479

    $                293,767

       Products and services

    26,520

    21,807

    Total revenue

    356,999

    315,574







    Cost of revenue:





       Cost of licensing

    21,110

    15,736

       Cost of products and services

    19,664

    16,324

    Total cost of revenue

    40,774

    32,060







    Gross profit

    316,225

    283,514







    Operating expenses:





       Research and development

    66,638

    67,033

       Sales and marketing

    94,399

    79,003

       General and administrative

    70,092

    65,166

       Restructuring charges

    5,216

    6,091

    Total operating expenses

    236,345

    217,293







    Operating income

    79,880

    66,221







    Other income/(expense):





       Interest income/(expense), net

    2,646

    9,187

       Other income, net

    3,525

    5,425

    Total other income

    6,171

    14,612







    Income before income taxes

    86,051

    80,833

    Provision for income taxes

    (17,981)

    (13,252)

    Net income including noncontrolling interest

    68,070

    67,581

    Less: net income attributable to noncontrolling interest

    (248)

    (600)

    Net income attributable to Dolby Laboratories, Inc.

    $                  67,822

    $                  66,981







    Net income per share:





       Basic

    $                      0.71

    $                      0.70

       Diluted

    $                      0.70

    $                      0.69

    Weighted-average shares outstanding:





       Basic

    95,615

    95,376

          Diluted

    97,147

    97,439

     

    DOLBY LABORATORIES, INC.

    INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

    (in thousands; unaudited)





    December 27,

    2024

    September 27,

    2024

    ASSETS





    Current assets:





    Cash and cash equivalents

    $                520,821

    $                482,047

    Restricted cash

    90,836

    95,705

    Accounts receivable, net

    339,304

    315,465

    Contract assets, net

    220,892

    197,478

    Inventories, net

    31,833

    33,728

    Prepaid expenses and other current assets

    82,113

    69,994

    Total current assets

    1,285,799

    1,194,417

    Long-term investments

    86,304

    89,267

    Property, plant, and equipment, net

    476,113

    479,109

    Operating lease right-of-use assets

    36,972

    39,046

    Goodwill and intangible assets, net

    941,661

    967,722

    Deferred taxes

    227,021

    219,758

    Other non-current assets

    104,732

    120,609

    Total assets

    $             3,158,602

    $             3,109,928







    LIABILITIES AND STOCKHOLDERS' EQUITY





    Current liabilities:





    Accounts payable

    $                  11,550

    $                  17,380

    Accrued liabilities

    360,915

    347,529

    Income taxes payable

    20,875

    9,045

    Contract liabilities

    37,111

    31,644

    Operating lease liabilities

    11,426

    12,238

    Total current liabilities

    441,877

    417,836

    Non-current contract liabilities

    32,481

    34,593

    Non-current operating lease liabilities

    33,019

    34,754

    Other non-current liabilities

    134,197

    135,852

    Total liabilities

    641,574

    623,035







    Stockholders' equity:





    Class A common stock

    55

    53

    Class B common stock

    40

    41

    Retained earnings

    2,543,413

    2,496,255

    Accumulated other comprehensive loss

    (35,542)

    (19,187)

    Total stockholders' equity – Dolby Laboratories, Inc.

    2,507,966

    2,477,162

    Noncontrolling interest

    9,062

    9,731

    Total stockholders' equity

    2,517,028

    2,486,893

    Total liabilities and stockholders' equity

    $             3,158,602

    $             3,109,928

     

    DOLBY LABORATORIES, INC.

    INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands; unaudited)





    Fiscal Quarter Ended



    December 27,

    2024

    December 29,

    2023

    Operating activities:





    Net income including noncontrolling interest

    $                  68,070

    $                  67,581

    Adjustments to reconcile net income to net cash provided by operating activities:





       Depreciation and amortization

    22,362

    17,872

       Stock-based compensation

    36,070

    31,894

       Amortization of operating lease right-of-use assets

    2,835

    3,088

       Amortization of premium on investments

    —

    (895)

       Provision for/(benefit from) credit losses

    730

    (2,101)

       Deferred income taxes

    (7,307)

    (5,397)

       Other non-cash items affecting net income

    (3,059)

    (1,745)

       Changes in operating assets and liabilities:





       Accounts receivable, net

    (24,647)

    (28,935)

       Contract assets, net

    (23,416)

    (35,400)

       Inventories

    1,340

    (9,297)

       Operating lease right-of-use assets

    (2,487)

    570

       Prepaid expenses and other assets

    16,867

    5,866

       Accounts payable and accrued liabilities

    4,804

    (31,993)

       Income taxes, net

    15,305

    6,184

       Contract liabilities

    3,691

    (1,116)

       Operating lease liabilities

    (798)

    (4,264)

       Other non-current liabilities

    (3,581)

    (3,503)

    Net cash provided by operating activities

    106,779

    8,409







    Investing activities:





    Purchases of marketable securities

    —

    (35,753)

    Proceeds from sales of marketable securities

    —

    1,226

    Proceeds from maturities of marketable securities

    —

    41,259

    Purchases of property, plant, and equipment

    (6,779)

    (6,099)

    Business combinations, net of cash and restricted cash acquired, and other related payments

    (1,362)

    —

    Net cash provided by/(used in) investing activities

    (8,141)

    633







    Financing activities:





    Proceeds from issuance of common stock

    22,157

    18,301

    Repurchase of common stock

    (15,000)

    (80,002)

    Payment of cash dividend

    (31,548)

    (28,552)

    Distributions to noncontrolling interest

    (740)

    (1,047)

    Shares repurchased for tax withholdings on vesting of restricted stock

    (32,440)

    (34,562)

    Equity issued in connection with business combination

    —

    722

    Net cash used in financing activities

    (57,571)

    (125,140)







    Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

    (7,162)

    6,790

    Net increase/(decrease) in cash, cash equivalents, and restricted cash

    33,905

    (109,308)

    Cash, cash equivalents, and restricted cash at beginning of period

    577,752

    817,966

    Cash, cash equivalents, and restricted cash at end of period

    $                611,657

    $                708,658

     

    Licensing Revenue by Market

    (unaudited)



    The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, except percentage amounts):





    Fiscal Quarter Ended

    Market

    December 27, 2024



    December 29, 2023

    Broadcast

    $            115,762

    35 %



    $            112,416

    38 %

    Mobile

    61,524

    19 %



    35,287

    12 %

    CE

    49,457

    15 %



    53,220

    18 %

    PC

    31,256

    9 %



    29,679

    10 %

    Other

    72,480

    22 %



    63,165

    22 %

    Total licensing revenue

    $            330,479

    100 %



    $            293,767

    100 %

     

    GAAP to Non-GAAP Reconciliations



    (unaudited)













    The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the first quarters of fiscal 2025 and fiscal 2024:













    Net income:



    Fiscal Quarter Ended



    (in thousands)



    December 27,

    2024

    December 29,

    2023



    GAAP net income attributable to Dolby Laboratories, Inc.



    $             67,822

    $             66,981



    Stock-based compensation (1)



    36,070

    31,894



    Amortization of acquisition-related intangibles (2)



    10,647

    3,124



    Restructuring charges



    5,216

    6,091



    Income tax adjustments



    (8,886)

    (9,450)



    Non-GAAP net income attributable to Dolby Laboratories, Inc.



    $            110,869

    $             98,640













    (1) Stock-based compensation included in above line items:









       Cost of products and services



    $                  487

    $                  410



       Research and development



    10,984

    10,106



       Sales and marketing



    12,645

    10,481



       General and administrative



    11,954

    10,897













    (2) Amortization of acquisition-related intangibles included in above line items:









       Cost of licensing



    $               6,704

    $                    62



       Cost of products and services



    834

    534



       Sales and marketing



    754

    656



       General and administrative



    1,872

    1,872



       Other income, net



    483

    —













    Diluted earnings per share:



    Fiscal Quarter Ended







    December 27,

    2024

    December 29,

    2023



    GAAP diluted earnings per share



    $                 0.70

    $                 0.69



    Stock-based compensation



    0.37

    0.33



    Amortization of acquisition-related intangibles



    0.11

    0.03



    Restructuring charges



    0.05

    0.06



    Income tax adjustments



    (0.09)

    (0.10)



    Non-GAAP diluted earnings per share



    $                 1.14

    $                 1.01























    Weighted-average shares outstanding - diluted (in thousands)



    97,147

    97,439



     

    The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the second quarter of fiscal 2025 and full year fiscal 2025 included in this release:















    Gross margin:





    Q2 2025





    Fiscal 2025

    GAAP gross margin





    89.0 %





    87.0 %

    Stock-based compensation





    0.1 %





    0.1 %

    Amortization of acquisition-related intangibles





    1.9 %





    2.9 %

    Non-GAAP gross margin





    91.0 %





    90.0 %















    Operating expenses (in millions):





    Q2 2025





    Fiscal 2025

    GAAP operating expenses (low - high end of range)





    $230 - $240





    $915 - $925

    Stock-based compensation





    (34)





    (131)

    Amortization of acquisition-related intangibles





    (3)





    (9)

    Restructuring charges





    (3)





    (10)

    Non-GAAP operating expenses (low - high end of range)





    $190 - $200





    $765 - $775















    Operating margin:









    Fiscal 2025

    GAAP operating margin











    20% +/-

    Stock-based compensation











    10 %

    Amortization of acquisition-related intangibles











    3 %

    Non-GAAP operating margin











    33% +/-















    Effective tax rate:











    Q2 2025

    GAAP effective tax rate











    20.5 %

    Stock-based compensation (low - high end of range)











    (2%) - 0%

    Amortization of acquisition-related intangibles (low - high end of range)











    (1%) - 0%

    Non-GAAP effective tax rate











    18.5 %















    Diluted earnings per share:



    Q2 2025



    Fiscal 2025





    Low

    High



    Low

    High

    GAAP diluted earnings per share (low - high end of range)



    $                 0.77

    $              0.92



    $                 2.39

    $              2.54

    Stock-based compensation



    0.34

    0.34



    1.36

    1.36

    Amortization of acquisition-related intangibles



    0.12

    0.12



    0.42

    0.42

    Restructuring charges



    0.03

    0.03



    0.10

    0.10

    Income tax adjustments



    (0.07)

    (0.07)



    (0.28)

    (0.28)

    Non-GAAP diluted earnings per share (low - high end of range)



    $                 1.19

    $              1.34



    $                 3.99

    $              4.14















    Weighted-average shares outstanding - diluted (in thousands)



    97,400

    97,400



    97,500

    97,500















    Investor Contact:

    Peter Goldmacher

    415-254-7415

    [email protected] 

    Media Contact:

    [email protected] 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-first-quarter-2025-financial-results-302363766.html

    SOURCE Dolby Laboratories, Inc.

    Get the next $DLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DLB

    DatePrice TargetRatingAnalyst
    6/3/2024$100.00Mkt Perform → Outperform
    Barrington Research
    11/18/2022Outperform → Mkt Perform
    Barrington Research
    5/24/2022$90.00Buy
    Rosenblatt
    8/2/2021$115.00Mkt Perform → Outperform
    Barrington Research
    More analyst ratings

    $DLB
    SEC Filings

    See more
    • SEC Form 10-Q filed by Dolby Laboratories

      10-Q - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:52:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:15:23 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SCHEDULE 13G/A filed by Dolby Laboratories

      SCHEDULE 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      4/30/25 10:55:37 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Financials

    Live finance-specific insights

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Reports First Quarter 2025 Financial Results

      SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories. "In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto." First Quarter Fiscal 2025 Financial Highlights Total revenue was $357 mil

      1/29/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby and AMC Entertainment announce major expansion of Dolby Cinema at AMC in the US, with 40 additional auditoriums to be added by the end of 2027

      AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan., March 31, 2025 /PRNewswire/ --  Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, and AMC Entertainment (NYSE:AMC), the largest theatrical exhibitor in the United States and in the world, today announced a significant expansion of their partnership, following a decade of success and guest popularity of the Dolby Cinema at AMC experience. Beginning this year, AMC and Dolby will add an additional 40 Dolby Cinema at AMC locations in the United States through the end of 2027.

      3/31/25 8:30:00 AM ET
      $AMC
      $DLB
      Movies/Entertainment
      Consumer Discretionary
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Leadership Updates

    Live Leadership Updates

    See more
    • OpenSesame Appoints Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors

      OpenSesame today announced it has appointed Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors. Dr. Elkeles is a highly regarded Chief Human Resources Officer and thought leader, advising globally on Talent, Learning, Human Resources, and Organization Development. Ms. Rollins has served hundreds of companies during her career at Deloitte, where she held various leadership positions in their U.S. Technology, Media, and Telecommunications practice, Audit Innovation and Transformation, and Diversity and Inclusion initiatives. Both executives bring decades of experience in technology, talent, finance, and governance to OpenSesame. Dr. Elkeles has spent 30 years in the human capit

      8/10/22 9:00:00 AM ET
      $DLB
      $GPX
      $SNCE
      $XMTR
      Multi-Sector Companies
      Miscellaneous
      Other Consumer Services
      Consumer Services
    • Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group

      SAN FRANCISCO, May 03, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, today announced the appointment of Dr. Shriram Revankar, a technologist and industry leader who has cultivated teams across multiple disciplines to deliver high impact technologies and world-class research, as its Senior Vice President Advanced Technology Group. Shriram will lead Dolby's global Advanced Technology Group building on the company's decades of innovation. Most recently, as Vice President and Fellow at Adobe, Shriram founded several of Adobe's global research labs, including the Big-Data Experience Lab and the Document Intelligence Lab. Through

      5/3/22 12:00:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Appoints Tony Prophet to its Board of Directors

      SAN FRANCISCO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) announced today the appointment of Tony Prophet to its Board of Directors, effective December 6, 2021. Over the course of many years, Tony has established himself as a technology industry leader who has helped guide companies across multiple disciplines. Most recently, Tony served as the Chief Equality and Recruiting Officer at Salesforce, co-chairing the Salesforce Racial Equality and Justice Task Force, created to help drive systemic change in the workplace and community. He was also a co-founder of the company's Ethical and Humane Use of technology initiative. During his time with Microsoft, Tony serve

      12/8/21 8:30:00 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      11/13/24 4:05:17 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      9/10/24 4:39:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G/A filed by Dolby Laboratories (Amendment)

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      2/13/24 5:02:35 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dolby Labs upgraded by Barrington Research with a new price target

      Barrington Research upgraded Dolby Labs from Mkt Perform to Outperform and set a new price target of $100.00

      6/3/24 9:17:02 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Labs downgraded by Barrington Research

      Barrington Research downgraded Dolby Labs from Outperform to Mkt Perform

      11/18/22 9:17:35 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Rosenblatt initiated coverage on Dolby Labs with a new price target

      Rosenblatt initiated coverage of Dolby Labs with a rating of Buy and set a new price target of $90.00

      5/24/22 7:27:36 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Entertainment Couling John D sold $50,652 worth of shares (675 units at $75.04), decreasing direct ownership by 0.55% to 121,151 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      5/7/25 4:47:24 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by President and CEO Yeaman Kevin J

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/28/25 4:04:04 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SVP, Chief Marketing Officer Pendleton Todd exercised 7,286 shares at a strike of $71.07 and sold $1,517,668 worth of shares (18,121 units at $83.75), decreasing direct ownership by 23% to 37,290 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/21/25 5:17:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Yeaman Kevin J bought $200 worth of shares (3 units at $78.15) (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      6/25/24 9:28:41 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous